October 7, 2026
Gillette Stadium, Foxboro, MA

2026 COMING SOON

Wednesday, October 7, 2026
Gillette Stadium, Foxborough, MA

Session 1: From Concept to Blockbuster: Navigating the Challenges of Drug Development and Commercialization

  • Posted by Amy Poole
  • On July 31, 2018
2:00 PM – 2:45 PM | East Red Level, Suite 10 From Concept to Blockbuster: Navigating the Challenges of Drug Development and Commercialization This session will examine the evolving challenges faced by biotech companies across different levels of company maturity: large-scale production, cell and gene therapy, and research and development. Understanding these challenges is crucial […]
Read More
 

Session 2: CMC Considerations for Personalized mRNA Therapies

  • Posted by Amy Poole
  • On July 12, 2018
2:00 PM – 2:45 PM | West Red Level, Suite 81 CMC Considerations for Personalized mRNA Therapies This presentation will explore the Chemistry, Manufacturing, and Controls (CMC) considerations unique to the development and production of personalized mRNA therapies. Specifically, attendees will learn: Key differences in CMC requirements between personalized mRNA therapies and precision mRNA therapeutics. […]
Read More
 

Session 4: Transforming Manufacturing Operations with Unified Data Environments

  • Posted by Amy Poole
  • On July 11, 2018
3:00 PM – 3:45 PM | West Red Level, Suite 81 Transforming Manufacturing Operations with Unified Data Environments In an era where digital transformation is key, manufacturing operations often struggle with siloed systems, non-standardized data, and limited governance, leading to hindered visibility and suboptimal decision making. This presentation will explore the journey towards creating a […]
Read More
 

Session 5: Phase-Appropriate and Risk-Based Quality Assurance Strategies for Phase 1 GMP of Cell and Gene Therapy Drug Products

  • Posted by Amy Poole
  • On June 21, 2023
4:00 PM – 4:45 PM | East Red Level, Suite 10 Phase-Appropriate and Risk-Based Quality Assurance Strategies for Phase 1 GMP of Cell and Gene Therapy Drug Products The development of cell and gene therapy (CGT) products brings unique challenges, particularly during Phase 1 GMP manufacturing, where patient safety, product quality, and regulatory compliance must […]
Read More
 

Session 6: Disrupting the Approach to Developing Advanced Modalities

  • Posted by Amy Poole
  • On June 21, 2023
4:00 PM – 4:45 PM | West Red Level, Suite 81 Disrupting the Approach to Developing Advanced Modalities To fully realize the potential of advanced modalities, our industry needs to take an innovative, collaborative, and strategic approach to development. Key decisions impacting a technology’s journey often occur in the early days of research. Broadening the […]
Read More
 

Keynote

  • Posted by Amy Poole
  • On July 11, 2018
10:00 AM – 11:30 AM | North GP Atrium, Club Level Keynote Session: Shaping the Future of Life Sciences Our keynote program opens with a special recognition of the first-ever Dan Rufo Scholars Award winner, Era Kalaja. A B.S./M.S. student in Computer Science and Data Science at Worcester Polytechnic Institute, Era is a trailblazer in applied […]
Read More
 

Emerging Leaders Session: The Lifecycle of a Drug Product

  • Posted by Amy Poole
  • On June 13, 2018
1:00 PM – 1:45 PM | West Red Level, Suite 81 The Lifecycle of a Drug Product This presentation will offer a high level overview of the lifecycle of a drug product, spanning from initial research and development to regulatory approval. We will examine the critical stages involved in bringing a therapy to market, including […]
Read More
 

CONTACT US
Phone: +1-781-647-4773
Email: office@ISPEBoston.org